BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 23, 2007
View Archived Issues
Animal models of colitis reveal potential of NU-206 treatment
Read More
Novel Alzheimer's vaccine candidate developed at UBI
Read More
Recent patents disclose novel therapeutic agents for respiratory and allergic disorders
Read More
Nonhematotoxic naphthalimide derivative and prodrug show promising preclinical activity
Read More
Schering-Plough selects collaborative compound for preclinical development
Read More
Recent Pfizer patent claims novel therapeutic agents for thrombocytopenia
Read More
Avexa and TargetDrug formalize CCR5 HIV drug program collaboration
Read More
Genta plans new phase III study of Genasense in advanced melanoma
Read More
Vasogen and Ferrer collaborate to commercialize Celacade in E.U., Latin America
Read More
New phase II trial studies anti-IgE immunotherapy RP-01
Read More
De Novo designs novel inhibitors for 11beta-hydroxysteroid dehydrogenase
Read More
Shire completes tender offer for New River shares
Read More
Indevus seeks to return Valstar to U.S. market
Read More
Novacea gains additional rights to AQ4N
Read More
European orphan drug designation for PDX in peripheral T-cell lymphoma
Read More
Access and Somanta sign definitive merger agreement
Read More
First phase II study under way for cetrorelix for BPH
Read More
Vaxfectin to be studied for use in malaria under new agreement
Read More
Merck KGaA and WHO conclude partnership for schistosomiasis in Africa
Read More
Japanese phase I trial completed for antiinfluenza drug CS-8958
Read More
E-2007 studied to lengthen effectiveness of L-dopa treatment in Parkinson's
Read More
Keppra effective as adjunctive therapy in partial onset seizures in young children
Read More
Anturol absorbed on bioequivalent basis from three application sites
Read More
NDA filing for fixed-dose Niaspan/simvastatin tablet
Read More
BGC-945 emerges as a tumor-targeted agent with minimal toxicity
Read More
Full FDA approval for DepoCyt for lymphomatous meningitis
Read More
MAb targeting DR5 induces apoptosis and tumor regression without toxicity
Read More
Potent and selective c-Met inhibitor described at AACR by Merck team
Read More